

Going around the bloc: Europe’s vaccination push
Dec 28, 2020
Join Christopher Lockwood, Europe editor for The Economist, and Lena Shipper, the Korea correspondent, as they dive into the EU's vaccination rollout amidst challenges of supply and public skepticism. They discuss how different member states are navigating their vaccination strategies and the implications for unity within the EU. Lena also explores South Korea's unique hiking culture, revealing its deep ties to national identity and individual reflection. Plus, insights into the changing dynamics of the British royal family add an intriguing twist!
AI Snips
Chapters
Transcript
Episode notes
EU Vaccination Push
- The EU began COVID-19 inoculations with the Pfizer-BioNTech vaccine, a "uniquely European story."
- Despite coordinated efforts, the bloc faces challenges in supply and uptake.
EU Approval Delay
- The EU's central approval for the vaccine was delayed compared to other countries due to the regulatory process.
- The European Medicals Agency required more data before approving the vaccine.
National Rollout Strategies
- Each EU country has a different vaccine rollout strategy, prioritizing different groups.
- Vaccine skepticism is prevalent, particularly in France, posing a challenge for widespread adoption.